Tenax Therapeutics
(TENX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,384 | 12,550 | 9,792 | 11,141 | 13,394 |
| Other current assets | 50 | 67 | 252 | 267 | 283 |
| TOTAL | $10,616 | $14,459 | $11,684 | $11,883 | $14,039 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 5 | 6 |
| Other Non-Current Assets | 1 | 1 | 1 | 1 | 1 |
| TOTAL | $1 | $1 | $1 | $6 | $7 |
| Total Assets | $10,617 | $14,460 | $11,685 | $11,889 | $14,046 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 870 | 1,081 | 2,073 | 135 | 207 |
| Accrued Expenses | 592 | 536 | 1,013 | 293 | 272 |
| TOTAL | $1,741 | $2,031 | $3,587 | $602 | $824 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,741 | $2,031 | $3,587 | $602 | $824 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,409 | 1,958 | 1,958 | 298 | 298 |
| Common Shares | 0 | 0 | N/A | 2 | 2 |
| Retained earnings | -304,627 | -301,052 | -297,253 | -294,027 | -292,055 |
| TOTAL | $8,876 | $12,430 | $8,098 | $11,287 | $13,222 |
| Total Liabilities And Equity | $10,617 | $14,460 | $11,685 | $11,889 | $14,046 |